DOI: 10.1128/mBio.00722-20
Article Information
PubMed
Published By
History
- Received March 23, 2020
- Accepted March 23, 2020
- Published online March 26, 2020.
Copyright & Usage
Copyright © 2020 Patel et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
Author Information
- Robin Patela, President, American Society for Microbiology,
- Esther Babadyb,
- Elitza S. Theela,
- Gregory A. Storchc,
- Benjamin A. Pinskyd,
- Kirsten St. Georgee,
- Tara C. Smithf,
- Stefano Bertuzzig, Chief Executive Officer, American Society for Microbiology
- aMayo Clinic, Rochester, Minnesota, USA
- bMemorial Sloan Kettering Cancer Center, New York, New York, USA
- cWashington University, Saint Louis, Missouri, USA
- dStanford University School of Medicine, Palo Alto, California, USA
- eWadsworth Center, New York State Department of Health, Albany, New York, USA
- fKent State University, Kent, Ohio, USA
- gAmerican Society for Microbiology, Washington, DC, USA
- Address correspondence to Robin Patel, patel.robin{at}mayo.edu.
Citation Patel R, Babady E, Theel ES, Storch GA, Pinsky BA, St. George K, Smith TC, Bertuzzi S. 2020. Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of diagnostic testing for SARS–CoV-2/COVID-19. mBio 11:e00722-20. https://doi.org/10.1128/mBio.00722-20.
